Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
7
×
biotech
boston blog main
boston top stories
7
×
clinical trials
7
×
life sciences
national blog main
fda
national top stories
san francisco blog main
allergan
national
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
anemia
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
europe blog main
europe top stories
glaxosmithkline
graybug vision
indiana blog main
indiana top stories
medical devices
new york blog main
new york top stories
novartis
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alzheimer's disease
What
bio
roundup
biotech
blood
cancer
days
fda
life
medicine
science
treatment
won
abbvie
abbvie’s
advance
ahead
alkermes
alliance
anemia
antipsychotic
august
benefits
biofourmis
black
body
broader
bucks
busy
carry
caveats
celebrate
cells
chance
commonly
companies
company
continue
corner
day
debut
Language
unset
7
×
Current search:
abbvie
×
unset
×
" boston top stories "
×
" clinical trials "
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Disc Medicine Launches With $50M to Advance New Anemia Treatments
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More